Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
12/2005
12/28/2005EP1332138B1 Radiopharmaceuticals for diagnosing alzheimer's disease
12/28/2005EP0971747B1 Contrast agents
12/28/2005CN1713925A Method for the production of hyperpolarized 129xe
12/27/2005US6979555 Hyaluronan receptor for endocytosis
12/27/2005US6979436 metal and peptide complexes and/or combinatorial libraries preferential for opioids receptors, which can transit the blood-brain barrier and having improved bioavailability and pharmacokinetics; drug screening and design; analgesics
12/22/2005WO2005121315A1 Cholesterol-producing yeast strains and uses thereof
12/22/2005WO2005120590A1 Activatable particles, preparations and uses.
12/22/2005WO2005120589A2 Contrast agent comprising alginate and an isotope or paramagnetic ion
12/22/2005WO2005120588A2 Peptides delivered to cell nuclei
12/22/2005WO2005120586A2 Copolymers comprising positively and negatively charged aminoacids conjugated to chelants
12/22/2005WO2005120585A1 Dual function polymer micelles
12/22/2005WO2005042029A3 Psma formulations and uses thereof
12/22/2005WO2004060317A3 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasia
12/22/2005WO2004000216A3 Anti-tenascin antibody fragments and minibodies for treatment of lymphoma
12/22/2005US20050282798 Pharmaceutical compounds
12/22/2005US20050281801 Glue composition for lung volume reduction
12/22/2005US20050281800 Targeting sites of damaged lung tissue
12/22/2005US20050281799 Targeting damaged lung tissue using compositions
12/22/2005US20050281798 Targeting sites of damaged lung tissue using composition
12/22/2005US20050281741 Using cyanine dyes; in situ target tumor cells
12/22/2005US20050281740 Imaging damaged lung tissue
12/22/2005US20050281739 Imaging damaged lung tissue using compositions
12/22/2005US20050281738 Method and means for detecting inflammatory processes
12/22/2005US20050281737 Stablilized and lyophilized radiopharmaceutical agents
12/22/2005DE102004026103A1 Trimere makrocyclisch substituierte Aminoisophthalsäure-Halogen-Benzolderivate Trimeric macrocyclic substituted aminoisophthalic-halo-benzene derivatives
12/22/2005CA2564197A1 Activatable particles, preparations and uses
12/22/2005CA2562773A1 Cholesterol-producing yeast strains and uses thereof
12/21/2005EP1606301A2 Aptamer therapeutics useful in ocular pharmacotherapy
12/21/2005EP1606012A2 Methods for protection from toxicity of alpha emitting elements during radioimmunotherapy
12/21/2005EP1605893A2 Trans-membrane-antibody induced inhibition of apoptosis
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/21/2005CN1711475A Detection, localization and staging of tumors using labeled activated lymphocytes directed to a tumor specific epitope
12/21/2005CN1711108A Method for the selective and quantitative functionalization of immunoglobulin Fab fragments, conjugate compounds obtained with the same and compositions thereof
12/21/2005CN1711106A Agents for the diagnosis and treatment of tumours that expose altered proteins on the cell surface
12/21/2005CN1709518A Polymeric polyglycolide-polylactide radioactive seed source thin-layer tablet and it spreparing method
12/21/2005CN1232525C Tc N dimercaptosuccinate compound, its preparation process and application in nucleic medicine science
12/20/2005US6977068 administering a colloid of a detectable marker encased in carbon; detecting the presence of the diagnostic particles binding to fibrin;
12/15/2005WO2005117999A2 Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface
12/15/2005WO2005117832A1 Liposomal assembly for therapeutic and/or diagnostic use
12/15/2005WO2005079155A3 Photoreactive compound specifically binding to calcium binding proteins
12/15/2005WO2005077962A3 Crowned dithiocarbamate metal complexes and methods for their use
12/15/2005US20050276756 Compositions as adjuvants to improve immune responses to vaccines and methods of use
12/15/2005US20050276755 Formulation of Tc and Re carbonyl complexes using stannous ion as the reductant for pertechnetate and perrhenate
12/15/2005US20050276754 Bridged aromatic substituted amine ligands with donor atoms
12/15/2005US20050276753 Administering positron emitting radiolabeled halogenated xanthene diagnostic agent, imaging tissue based on detection of gamma ray photons produced upon annihilation of positrons emitted from the diagnostic agent
12/15/2005US20050276752 halogenated xanthene derivatives such as 4,5,6,7-tetrachloro-2',4',5',7'-tetraiodofluorescein, used for imaging human and animal tissues; tomography
12/15/2005US20050276751 System and method for an automated synthesis of gallium-68 generator-based radiopharmaceutical agents
12/15/2005US20050276750 2-Amino-4-{(2-{(3-amino-3-carboxy-propyl)-[2-(4-methoxy-benzylsulfanyl)-ethyl]-amino}-ethyl)-[2-(4-methoxy-benzylsulfanyl)-ethyl]-amin o}-butyric acid; detection of cells undergoing apoptosis, blood clot, activated inflammatory cells, cell death within tumor, metastases, cell having perturbed membrane
12/15/2005CA2572453A1 Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface
12/15/2005CA2572451A1 Annexin a1 based vascular targets for detecting, imaging and treating neoplasia or neovasculature
12/14/2005EP1604689A1 Simultaneous multimodal measurement of physiological function
12/14/2005EP1603598A2 Radiolabeled conjugates based on substance p and the uses thereof
12/14/2005EP1603535A2 Aromatase inhibitor diagnosis and therapy
12/14/2005EP0927045B1 Tumor homing molecules, conjugates derived therefrom, and methods of using same
12/14/2005CN1708322A Conjugates of TC complexes and targeting moieties and their use in MRI diagnostic
12/14/2005CN1708321A Radioactive transition metal-imido hetero-diphosphine complexes, their preparation and radiopharmaceutical compositions thereof
12/14/2005CN1708317A Combination therapy with class III anti-CEA monoclonal antibodies and therapeutic agents
12/14/2005CN1231483C 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives
12/13/2005US6974791 These peptides possess a charge motif of positive-positive-hydrophobic which is important in determining the specificity of binding to tumor-derived endothelium.
12/13/2005US6974567 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
12/08/2005WO2005116255A2 Aptamer-toxin molecules and method for using same
12/08/2005WO2005116226A2 Nanoparticles comprising rna ligands
12/08/2005WO2005116065A1 Labelled adrenomedullin derivatives and their use for imaging and therapy
12/08/2005WO2005116058A1 Peptides useful for treating gnrh associated diseases
12/08/2005WO2005115997A1 Trimeric macrocyclic substituted aminoisophthalate halophenyl derivatives
12/08/2005WO2005115971A1 Radioactive tyrosine derivative, method for producing same, labeling agent for positron imaging and medical agent for assessing grade of malignancy of tumor respectively composed of radioactive tyrosine derivative, and method for detecting tumor
12/08/2005US20050272677 Delivery of a substance to a pre-determined site
12/08/2005US20050271745 Magnetic nanoparticle compositions, and methods related thereto
12/08/2005US20050271673 Trifunctional reagent for conjugation to a biomolecule
12/08/2005US20050271592 Optical diagnostic and therapeutic agents and compositions
12/08/2005US20050271589 For therapy of cancer; for therapy of disorders associated with voltage-gated ion channels, ligand gated channels and other receptors
12/08/2005US20050271588 Liposome targeting of matrix metalloproteinase inhibitors
12/08/2005US20050271587 Exposing the cancer cell to a peptide has antiestrotrophic activity and is eight to twenty amino acids long; use of tamoxifen therapy in combination with the peptide therapy
12/08/2005US20050271585 Extended conjugated polymers
12/08/2005US20050271584 Biphenyls and fluorenes as imaging agents in alzheimer's disease
12/08/2005CA2567478A1 Labelled adrenomedullin derivatives and their use for imaging and therapy
12/07/2005EP1602668A1 Monoclonal antibodies specific to VEGF receptors and uses thereof
12/07/2005EP1602658A1 Tricyclic pyrazole derivatives as cannabinoid receptor antagonists
12/07/2005EP1602381A1 Contrast agent for combined modality imaging and methods and systems thereof
12/07/2005EP1601384A1 Methods of radiofluorination of biologically active vectors
12/07/2005EP1601383A2 Method for continuous visualization of a body lumen
12/07/2005EP1601367A2 The combined use of cruciferous indoles and chelators for the treatment of papillomavirus-related conditions
12/07/2005EP0949920B1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
12/07/2005EP0755269B1 Contrast agents
12/07/2005EP0697893B1 Neural thread protein gene expression and detection of alzheimer's disease
12/07/2005CN1230536C Tie-2 ligands, methods of making and uses thereof
12/07/2005CN1230446C Antibodies and FV fragment recognizing antigen IORC2
12/07/2005CN1230443C Radio-labeled compound for imaging of thrombus
12/07/2005CN1230441C Integrin binding peptide derivatives
12/01/2005WO2005113720A2 A strategy for designing patient-specific anti-cancer drugs
12/01/2005WO2005113601A2 Antibodies and molecules derived therefrom that bind to steap-1 proteins
12/01/2005WO2005113011A2 Prodrugs of ion channel modulating compounds and uses thereof
12/01/2005WO2005103081A3 Human monoclonal antibodies against cd20
12/01/2005WO2005099776A9 Steroid sparing agents and methods of using same
12/01/2005WO2005057589A3 Multi-purpose automated radiotracer synthesizer
12/01/2005US20050267127 Guanidino phenylalanin compounds used as urokinase inhibitors
12/01/2005US20050267027 Use of erythropoietin for treatment of cancer
12/01/2005US20050266483 Novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
12/01/2005US20050265926 Methods and reagents for improving localization of treatment and visualization ligands to sites in a mammal
12/01/2005US20050265922 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof
1 ... 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 ... 243